SPY757.12+0.19%QQQ692.74+0.33%BTC/USD77,729.99+0.38%DIA517.65+0.10%GLD356.15+0.10%TLT81.65−0.23%
BenzingaPremium Services
Premium Services

Second-Quarter Earnings

Second-quarter earnings represent the financial performance of a company during the second quarter of its fiscal year, typically covering April through June for calendar-year firms. These reports include revenue, net income, and other key metrics, providing investors and analysts with insights into operational trends, profitability, and future guidance. They play a critical role in influencing stock prices and market sentiment.

Bitcoin Hovers Near $80,000, Ethereum, XRP Spike, but Dogecoin Slips As Crypto Rally Gains Steam: Analyst Spots This New Bullish Signal for BTC
Bitcoin Hovers Near $80,000, Ethereum, XRP Spike, but Dogecoin Slips As Crypto Rally Gains Steam: Analyst Spots This New Bullish Signal for BTC
Peter Thiel-Backed Bullish Sees Tokenized Stocks as a 'Giant Growth Opportunity' No One Saw Coming
Peter Thiel-Backed Bullish Sees Tokenized Stocks as a 'Giant Growth Opportunity' No One Saw Coming
Peter Thiel-Backed Q2 Numbers Hit This Week: Will the Crypto Exchange Defy Sluggish Volumes and Post an Earnings Beat?
Peter Thiel-Backed Q2 Numbers Hit This Week: Will the Crypto Exchange Defy Sluggish Volumes and Post an Earnings Beat?
Peter Thiel-Backed Bullish Sees Tokenized Stocks as a 'Giant Growth Opportunity' No One Saw Coming
Peter Thiel-Backed Bullish Sees Tokenized Stocks as a 'Giant Growth Opportunity' No One Saw Coming
Peter Thiel-Backed Q2 Numbers Hit This Week: Will the Crypto Exchange Defy Sluggish Volumes and Post an Earnings Beat?
Peter Thiel-Backed Q2 Numbers Hit This Week: Will the Crypto Exchange Defy Sluggish Volumes and Post an Earnings Beat?
Will PLTR Surge Past $150 in August? Crypto Punters Raise the Stakes After Palantir's Solid Q2 Earnings
Will PLTR Surge Past $150 in August? Crypto Punters Raise the Stakes After Palantir's Solid Q2 Earnings
HOOD Q2 Earnings Countdown: What Awaits Vlad Tenev-Led Fintech Firm After Robinhood Chain's Successful Launch
HOOD Q2 Earnings Countdown: What Awaits Vlad Tenev-Led Fintech Firm After Robinhood Chain's Successful Launch

Second-Quarter Earnings Recent News

Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
Irish psychedelic biotech firm GH Research PLC (NASDAQ: GHRS) reported on Tuesday financial results for the second quarter ended June 30, 2024. Cash, cash equivalents, other financial assets and marketable securities were $204.5 million as of June 30, 2024, compared to cash, cash equivalents, other financial assets and marketable securities of $222.7 million as of December 31, 2023.The net loss was $10.4 million, or $0.20 loss per share, for the quarter that ended June 30, 2024, compared to the $7.7 million or $0.15 loss per share for the same quarter in 2023. The Dublin-based company also provided an update on its DMT-related drugs that are currently undergoing clinical trials.
Entourage Cannabis Co.'s Q2 Revenue Drops Nearly 9% YoY, CEO 'Optimistic' About Future Opportunities
Entourage Cannabis Co.'s Q2 Revenue Drops Nearly 9% YoY, CEO 'Optimistic' About Future Opportunities
Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its second quarter financial results for the three-month period ending June 30, 2024. The Toronto-based company reported a total revenue of CA$12.2 million ($9 million), including net revenue of $9.3 million, before excise duties and discounts, representing a decrease from CA$13.4 million in the prior year's period. The company touted "strong impact" with new product launches in Alberta, Ontario, and British Columbia.
Vext Cannabis Co.'s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver
Vext Cannabis Co.'s Q2 Revenue Drops Over 8% YoY, But Top Cannabis Analyst Sees Ohio Market As Major Growth Driver
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) reported its second-quarter financial results for the period ended June 30, 2024. The company reported a year-over-year drop in revenue from $9.2 million in the second quarter of fiscal 2023, to $8.4 million in this year's corresponding period. As a company with vertical operations in Arizona and Ohio, it is expected to benefit from the recent launch of recreational cannabis sales in the Buckeye State. Vext secured Certificates of Operation for the dual licensing of its cultivation and manufacturing facility as well as its operated dispensaries in Jackson and Columbus and received approval from the Ohio Division of Cannabis Control to begin selling adult-use cannabis in August.
Auxly Cannabis Co Sets Q2 Record In Revenue Following 33% YoY Increase, Reports Best Quarter In History
Auxly Cannabis Co Sets Q2 Record In Revenue Following 33% YoY Increase, Reports Best Quarter In History
Cannabis consumer packaged goods company Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) announced on Thursday its second quarter financial results for the three months ended June 30, 2024, revealing net revenues of CA$29.2 million. ($21.3 million). That's an increase of 33% year-over-year and 16% compared to the previous quarter. "After our best start to a year ever, we are thrilled to report our best Q2 in history, with exceptional financial performance setting a new Q2 record in revenue and all-time records in gross margin and adjusted EBITDA," Hugo Alves, CEO of Auxly, said. "We are particularly proud of our significant gains in market share across all three of our core product categories, especially in the vapor segment where we are currently leading the growing all-in-one category, securing an impressive 32% share of market."
Cannabis-Focused Software Co. SpringBig Narrows Q2 Net Loss, Reports 8.3% YoY Drop In Revenue
Cannabis-Focused Software Co. SpringBig Narrows Q2 Net Loss, Reports 8.3% YoY Drop In Revenue
SpringBig Holdings, Inc. (OTCQX: SBIG) a of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs, announced on Tuesday its financial results for the second quarter ended June 30, 2024. Revenue for the period totaled $6.6 million, down from $7.2 million in the prior year quarter and up from the previous period. Jeffrey Harris, the company's CEO and chairman said "we are pleased to report 2% quarter-over-quarter revenue growth in challenging macroeconomic conditions."
Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches
Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches
Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) reported on Wednesday its unaudited interim financial results for the second quarter ending June 30, 2024. "Decibel has shown good discipline in reducing our current liabilities by ~5mm this quarter," Benjamin Sze, Decibel's CEO, said. "Market share has been challenged but early indications from Qwest relaunch suggest we will regain market share in flower.  A continued focus on execution and capital efficiency will serve as the platform for future growth." The company reported net revenue of CA$22.1 million ($16.1 million), down from CA$28.5 million in the prior year's period, representing a 22% year-over-year drop. Its first quarter report published this past April revealed a 16% year-over-year revenue drop to CA$21 million and an adjusted net loss of CA$3.5 million.
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an 8% year-over-year and 6% sequential increase to CA$10.3 million ($7.5 million). "We are very pleased with our Q2 results, showcasing substantial improvements in both revenue and profitability," David Pidduck, the company's CEO, said. "The strategic initiatives implemented, including cost reductions and operational efficiencies, are yielding positive results. We are particularly encouraged by the continued growth in our international sales and the progress in innovation of non-combustible cannabis formats."
Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2
Hemp-Focused CV Sciences Reports Flat Revenue And Over 8% YoY Increase In Gross Profit In Q2
CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Tuesday its financial results for the second quarter that ended June 30, 2024, revealing a flat revenue year-over-year at $4 million for the period. "Revenues for our core business remained stable at $4 million in the second quarter of 2024 despite a challenging environment," Joseph Dowling, CEO of CV Sciences, said. "With our recently completed acquisitions and new product innovations, we are planning to grow our revenue in the second half of 2024. Our 47.0% gross margin in the second quarter of 2024 is our best gross margin in the last 13 quarters."
Canadian Cannabis Operations Drive Growth For Village Farms In Q2, Plans To Cash In On Marijuana Program In The Netherlands
Canadian Cannabis Operations Drive Growth For Village Farms In Q2, Plans To Cash In On Marijuana Program In The Netherlands
Village Farms International, Inc. (NASDAQ: VFF) today reported its financial results for the second quarter that ended June 30, 2024, revealing that total sales grew 19% year-over-year to $92.1 million for the period. The Vancouver-based company said Canadian cannabis grew net sales by 45% and retail branded sales by 35% year-over-year, as well as another quarter of positive adjusted EBITDA and operating cash flow.Michael DeGiglio, president and CEO of Village Farms, said the company is "driving strong momentum in our Canadian Cannabis business."
Highest On Record - Cronos Group Reports 46% YoY Increase In Q2 Net Revenue
Highest On Record - Cronos Group Reports 46% YoY Increase In Q2 Net Revenue
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Tuesday its 2024 second-quarter business results. The company reported $27.8 million in net revenue during the quarter, representing a 46% year-over-year increase. Mike Gorenstein, chairman, president and CEO of Cronos, said that's the "highest quarterly net revenue on record."
Trulieve Touts Third Consecutive Quarter Of Revenue Growth, Narrows Q2 Net Loss 97% YoY, Launches Cannabis Sales In Ohio
Trulieve Touts Third Consecutive Quarter Of Revenue Growth, Narrows Q2 Net Loss 97% YoY, Launches Cannabis Sales In Ohio
Trulieve Cannabis Corp. announced on Tuesday its second-quarter results for the three months ended June 30, 2024. The Florida medical cannabis giant reported a 2% quarter-over-quarter and 8% year-over-year increase to $303 million, with 95% of the sum coming from retail sales, driven by higher retail traffic and increased wholesale revenue.
Zig-Zag Segment On Sustainable Growth Trajectory, Turning Point CEO Reports 7% YoY Improvement In Adjusted EBITDA, Raises 2024 Guidance
Zig-Zag Segment On Sustainable Growth Trajectory, Turning Point CEO Reports 7% YoY Improvement In Adjusted EBITDA, Raises 2024 Guidance
Turning Point Brands, Inc. (NYSE: TPB), a maker of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced on Thursday financial results for the second quarter ended June 30, 2024. The company said adjusted EBITDA for the quarter came in positive at $27 million, representing a year-over-year improvement of 7%. That said, Turning Point has increased its full-year 2024 adjusted EBITDA guidance to $98 to $102 million. "We were pleased by our second quarter results," Graham Purdy, president and CEO, said. "We achieved our highest quarterly EBITDA since the second quarter of 2021."
Cannabis Companies About To Release Earnings Reports, Get Your News Here: Glass House, Schwazze And More
Cannabis Companies About To Release Earnings Reports, Get Your News Here: Glass House, Schwazze And More
Glass House Brands Inc. (OTCQX: GLASF) (OTC: GHBWF) is about to report financial results for the second quarter ended June 30, 2024, on Tuesday, August 13, 2024, after market close.Medicine Man Technologies, Inc., operating as Schwazze, (OTC: SHWZ) (Cboe CA: SHWZ) will host a conference call on Tuesday, August 13, 2024, at 5:00 pm Eastern time to discuss its financial and operational results for the second quarter ended June 30, 2024. Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) a cannabis-infused beverage maker, will hold a conference call on Tuesday, August 13, 2024, at 4:30 pm Eastern Time to discuss its financial results for the second quarter that ended June 30, 2024.SHF Holdings, Inc., which is doing business as Safe Harbor Financial (NASDAQ: SHFS) will report financial results for the second quarter of 2024 ending June 30, 2024, on Wednesday, August 14, 2024, after the close of the market.
Canadian Cannabis Extractor Ayurcann's Q2 Revenue Jumps Over 81% YoY, Net Loss Grows
Canadian Cannabis Extractor Ayurcann's Q2 Revenue Jumps Over 81% YoY, Net Loss Grows
Ayurcann Holdings Corp. saw a 81% year-over-year increase in net revenue to CA$5.8 million ($4.3 million) in the second quarter of fiscal 2024. The Toronto-based cannabis company specializes in manufacturing derivative cannabis products for the recreational market, securing 22 new stock-keeping units in various categories across several Canadian provinces. In the second quarter of fiscal 2024, the company reported a net loss of CA$771,622, with expenses amounting to CA$2.7 million and a gross margin of 37%. By the end of 2023, Ayurcann had total assets of CA$16.2 million and total liabilities of CA$14.2 million. Overall, for the first half of 2024, Ayurcann achieved a total net revenue of CA$12.3 million, with a decreased net loss of CA$951,267, expenses of CA$5.07 million, and a gross margin of 36%.
Tilray's Diversified Growth Strategy Is Paying Off, Here's What's Behind 34% YoY Revenue Increase In Q2
Tilray's Diversified Growth Strategy Is Paying Off, Here's What's Behind 34% YoY Revenue Increase In Q2
Canadian cannabis company Tilray reported a 34% increase in revenue in its second quarter of fiscal 2024. The company reported revenue of $194 million, up from $145 million in the same period last year. Tilray's cannabis net revenue increased 35% to $67 million, while beverage alcohol net revenue increased 117% to $47 million. Distribution net revenue also rose to $67 million, compared to $60 million in the same quarter last year. The company's gross profit increased 11% to $47 million, with adjusted gross profit up 18% to $52 million. Net loss in the second quarter amounted to $46 million, compared to a net loss of $62 million in the same period last year. Adjusted EBITDA stood at $10.1 million, down from $11 million in Q2 2023.
Vancouver Cannabis Producer Reports 17th Consecutive Quarter Of Positive Cash Flow Amid Industry Headwinds
Vancouver Cannabis Producer Reports 17th Consecutive Quarter Of Positive Cash Flow Amid Industry Headwinds
Cannabis company C21 Investments Inc.
Two Key Cannabis Trends Surged - Entourage Health's Financial Results Show Why
Two Key Cannabis Trends Surged - Entourage Health's Financial Results Show Why
Canadian cannabis producer Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) reported on Wednesday financial results for the three months ended June 30, 2023.
RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market
RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market
Cannabis-focused acquisition and investment firm RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) reported on Monday its second-quarter financial results for the three months ended on June 30, 2023.
Canadian Cannabis Producer Reduces Net Loss In Q2, Reports Drop In Revenue And Gross Profit Improvement
Canadian Cannabis Producer Reduces Net Loss In Q2, Reports Drop In Revenue And Gross Profit Improvement
Red White & Bloom Brands Inc. (CSE: RWB) (OTC: RWBYF) reported on Tuesday its condensed interim consolidated unaudited financial results for its second quarter ended June 30, 2023.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved